AdvanDx Test Shown to Reduce Mortality for Patients with BSIs
AdvanDx announces that a new medical study demonstrated use of its PNA FISH test reduced mortality by 42% for patients with highly drug resistant Hospital-Acquired Enterococcus faecium bloodstream infections (BSIs)
Read More